NCT01221649

Brief Summary

The new BIOTRONIK implantable cardioverter defibrillator (ICD) family Lumax 540 is capable of measuring the intrathoracic impedance on a daily basis and transmission of impedance trend data via the Home Monitoring technology. In future, this will allow for automatic early detection of imminent decompensation at a presymptomatic stage and immediate initialization of clinical meaningful therapeutic interventions preventing heart failure (HF) related hospitalizations. The aim of this investigation is to record long-term impedance trends in heart failure patients with and without heart failure related events (hospitalizations due to acute decompensation) in order to develop algorithms for device-based early detection and warning of HF deterioration accompanied by pulmonary congestion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
198

participants targeted

Target at P50-P75 for phase_4 heart-failure

Timeline
Completed

Started Jun 2010

Typical duration for phase_4 heart-failure

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 12, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 15, 2010

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

October 12, 2015

Status Verified

February 1, 2012

Enrollment Period

3.7 years

First QC Date

October 12, 2010

Last Update Submit

October 8, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • HF Events

    Long-term impedance trends in patients with clinically relevant HF events, to support the development of impedance based detection algorithms. A posterior assessment of sensitivity and false alarm rate of the detection algorithms.

    21 months follow-up

Interventions

ICD/CRT-DDEVICE

BIOTRONIK ICD family Lumax 540 and its successors

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current guidelines or patient already implanted with a Lumax 540 device or successor
  • New York Heart Association (NYHA)-class II to IV
  • Left ventricular ejection fraction (LVEF) lower or equal to 35%
  • Patient accepts Home Monitoring concept and has sufficient Global System for Mobile Communications (GSM) /General Packet Radio Service (GPRS) net coverage
  • Increased risk for HF-related hospitalization according to pre-defined criteria
  • Patient information
  • Informed consent

You may not qualify if:

  • Age \< 18 years
  • Contraindication for ICD implantation
  • Post heart transplant (HTX) or actively listed for HTX
  • Acute coronary syndrome within the previous 3 months
  • Chronic renal dialysis
  • Pregnant or breast-feeding women
  • Limited contractual capability
  • Participation in another study
  • Anticipated non-compliance with the follow-up scheme
  • Life expectancy not longer than 1.5 years due to a non-cardiac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Kokura Kinen Hospital

Kitakyushu, Fukuoka, 802-8555, Japan

Location

Hiroshima Shimin Hospital

Hiroshima, Hiroshima, Japan

Location

Yamada Red Cross Hospital

Ise, Mie-ken, 516-0805, Japan

Location

Tokyo Women's Medical University

Tokyo, Tokyo, Japan

Location

Related Publications (1)

  • Maier SKG, Paule S, Jung W, Koller M, Ventura R, Quesada A, Bordachar P, Garcia-Fernandez FJ, Schumacher B, Lobitz N, Takizawa K, Ando K, Adachi K, Shoda M. Evaluation of thoracic impedance trends for implant-based remote monitoring in heart failure patients - Results from the (J-)HomeCARE-II Study. J Electrocardiol. 2019 Mar-Apr;53:100-108. doi: 10.1016/j.jelectrocard.2019.01.004. Epub 2019 Jan 25.

MeSH Terms

Conditions

Heart FailureArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Shoda Morio, DR

    Tokyo Women's University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 12, 2010

First Posted

October 15, 2010

Study Start

June 1, 2010

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

October 12, 2015

Record last verified: 2012-02

Locations